Studies in several distinct animal models, each driven either by Aβ, inflammation, or tau, showed that spatial learning deficits are reversed with small molecule inhibitors of p38α kinase activity [18–20], providing direct evidence that p38α inhibition could be beneficial in AD. Here, MAPT is linked to Alzheimer disease.